Kiniksa Pharmaceuticals, Ltd.

NASDAQ:KNSA

26.25 (USD) • At close September 19, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

2024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42019 Q32019 Q22019 Q12018 Q42018 Q32018 Q22018 Q12017 Q42017 Q1
Assets:
Current Assets:
Cash & Cash Equivalents 99.271141.078107.954117.828112.56780.618122.715175.76194.30763.324122.47190.183167.953119.856114.03885.874123.456106.33646.928258.745287.447326.533307.304337.863285.518221.10845.555-55.97
Short Term Investments 119.48772.47498.41783.25672.425106.87667.89324.96343.90182.25359.7311057.913144.169209.444278.521128.94297.87186.452189.936204.637243.904235.328268.273.67200111.94
Cash and Short Term Investments 218.758213.552206.371201.084184.992187.494190.608200.724138.208145.577182.201200.183225.866264.025323.482364.395252.398204.206233.38258.745287.447326.533307.304337.863359.19221.10845.55555.97
Net Receivables 20.45115.99521.2663.04124.657.42420.31611.1597.80829.443.9853.2242.5510.2100000000000000
Inventory 34.85827.27831.12225.58323.95823.42521.59914.62119.91613.2233.6755.6066.3812.18900000000000000
Other Current Assets 26.95413.76617.53826.40112.44150.88210.53715.31114.00610.5176.5858.4999.8029.149.55714.01812.0958.8498.2479.5959.0118.4236.4463.6654.4161.241.4440
Total Current Assets 301.021270.591276.297256.109184.992231.5243.06241.815179.938198.757196.446217.512244.81275.564333.249378.413264.493213.055241.627268.34296.458334.956313.75341.528363.869222.45347.10455.97
Non-Current Assets:
Property, Plant & Equipment, Net 12.40413.03612.66513.58614.3271.3937.0438.1686.2197.298.3849.2968.8359.79710.6175.7396.5337.4338.3258.6278.8629.5376.3562.360.350.1260.1250
Goodwill 0000000000000000000000000000
Intangible Assets 16.751717.2517.517.751818.2518.518.751919.2519.519.752000000000000000
Goodwill and Intangible Assets 16.751717.2517.517.751818.2518.518.751919.2519.519.752000000000000000
Long Term Investments -0-244.954-00000000000000000000000000
Tax Assets 204.349214.918219.283193.574203.862184.418185.495185.8430000000.010.00305.414.3724.6282.6071.4561.2161.1730.70.3780.2380
Other Non-Current Assets 7.904249.0820.8272.2942.3537.5515.8245.6275.6695.9188.726.5515.8135.7975.5880.2580.4150.210.210.210.210.210.6432.040.211.8180.025-55.97
Total Non-Current Assets 241.407249.082250.025226.954238.292211.362216.612218.13830.63832.20836.35435.34734.39835.59416.21566.94813.05312.90713.46511.67911.2038.2155.5731.262.3220.388-55.97
Total Assets 542.428519.673526.322483.063484.332442.862459.672459.953210.576230.965232.8252.859279.208311.158349.464384.413271.441226.108254.534281.805308.137346.159321.965347.101365.129224.77547.4920
Liabilities & Equity:
Current Liabilities:
Account Payables 7.3935.6328.2461.0120.6481.3917.8991.4692.5223.3831.8681.6494.1562.7630.5033.9252.3734.2745.6936.449.3386.8910.9184.6680.5612.7961.2180
Short Term Debt 2.0852.2792.2532.3132.2383.4823.3013.2743.3363.3113.3813.2462.6362.3742.1071.4921.681.6891.6971.611.4961.384000000
Tax Payables 0000000000000000000000000000
Deferred Revenue 0.0120.1560.3072.5644.6746.4951212.092121238.03128.52831.064029.19900020.415019.17927.234000000
Other Current Liabilities 74.80156.14552.8647.57939.91225.21923.86639.65725.68631.661.5441.0040.92630.3160.03719.47516.49913.3790.02519.510.1651.38431.63623.35322.58316.47216.2120
Total Current Liabilities 84.29164.21263.66653.46847.47236.58747.06656.49243.54450.35444.82434.42738.78235.45331.84624.89220.55219.34227.8327.5630.17836.89242.55428.02123.14419.26817.430
Non-Current Liabilities:
Long Term Debt 9.3179.86410.00510.65111.2832.1332.6183.4351.2782.0962.6693.4993.54.24.8780.0550.1390.5510.9551.3911.8192.239000000
Deferred Revenue Non-Current 11.79911.81111.95411.87212.00612.1631214.1981212000000000000000000
Deferred Tax Liabilities Non-Current 00000000000000000000001.2161.1730000
Other Non-Current Liabilities 1.9261.8911.8581.9451.9151.8841.8391.820.260.2710.270.8851.1410.8090.8050.9570.3340.3810.3260.9430.9430.509-1.072-1.0060.1860.03119.770
Total Non-Current Liabilities 23.04223.56623.81724.46825.20416.1816.45719.45313.53814.3672.9394.3844.6415.0095.6831.0120.4730.9321.2812.3342.7622.7480.1440.1670.1860.03119.770
Total Liabilities 107.33387.77887.48377.93672.67652.76763.52375.94557.08264.72147.76338.81143.42340.46237.52925.90421.02520.27429.11129.89432.9439.6442.69828.18823.3319.298137.20
Equity:
Preferred Stock 0.11000000000000000000000000310.592119.7779.897
Common Stock 0.020.020.020.0150.0140.0140.0190.0190.0190.0190.0180.0180.0180.0180.0180.0180.0160.0150.0150.0150.0150.0150.0130.0130.0130.0110.0010
Retained Earnings -499.562-495.654-477.95-503.187-489.332-504.304-492.034-496.495-720.588-700.607-675.397-639.064-608.52-566.957-517.473-463.816-419.98-382.511-356.092-324.295-297.237-260.046-194.225-151.645-127.239-106.98-90.9980
Accumulated Other Comprehensive Income/Loss -0.13-0.0530.006-0.0010.0130.0550.044-0.07-0.09-0.103-0.066-0.0450.027-0.021-0.0340.0060.0090.240.0330.0620.1010.008-0.004-0.0550.007-0.042-0.052-25.732
Other Total Stockholders Equity 934.657927.582916.763-0.014-0.027-0.069-0.0630.0510.0710.084860.482853.139844.26837.656829.424822.301670.371588.09581.467576.129572.318566.542473.483470.6469.0181.896-118.4290
Total Shareholders Equity 435.095431.895438.839-503.187-489.332-504.304-492.034-496.495-720.588-700.607185.037214.048235.785270.696311.935358.509250.416205.834225.423251.911275.197306.519279.267318.913341.799205.477-89.70854.165
Total Equity 435.095431.895438.839-503.187-489.332-504.304-492.034-496.495-720.588-700.607185.037214.048235.785270.696311.935358.509250.416205.834225.423251.911275.197306.519279.267318.913341.799205.477-89.70854.165
Total Liabilities & Shareholders Equity 542.428519.673526.322-425.251-416.656-451.537-428.511-420.55-663.506-635.886232.8252.859279.208311.158349.464384.413271.441226.108254.534281.805308.137346.159321.965347.101365.129224.77547.49254.165